Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcomas
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference27 articles.
1. New guidelines to evaluate the response to treatment in solid tumors;Therasse;J. Natl. Cancer Inst.,2000
2. Optimal two-stage designs for phase II clinical trials;Simonm;Controlled Clinical Trials,1989
3. One-sample multiple testing procedure for phase II clinical trials;Fleming;Biometrics,1982
4. The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent;Gehan;J. Chron. Dis.,1961
5. Clinical designs for cytostatic agents;Korn;J. Clin. Oncol.,2001
Cited by 382 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Outcome of patients with relapsed or refractory nonrhabdomyosarcoma soft tissue sarcomas enrolled in phase 2 cooperative group clinical trials: A report from the Children’s Oncology Group;Cancer;2024-03-12
2. Regorafenib in advanced solitary fibrous tumour: Results from an exploratory phase II clinical study;European Journal of Cancer;2023-12
3. SAR-096: Phase II Clinical Trial of Ribociclib in Combination with Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS);Clinical Cancer Research;2023-11-15
4. Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/CDKN2A;Signal Transduction and Targeted Therapy;2023-10-25
5. Immune-related Adverse Events after Immune Checkpoint Blockade–based Therapy Are Associated with Improved Survival in Advanced Sarcomas;Cancer Research Communications;2023-10-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3